Background. Endothelial activation may contribute to development of severe disease from Plasmodium falciparum infection, but optimal markers of endothelial activation in severe malaria, the extent of endothelial activation in asymptomatic infection, and the effect of blood group O on endothelial activation have not been defined. Methods. Serum levels of 3 markers of endothelial activation-von Willebrand factor (VWF), soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1)-were assessed in Ugandan children with cerebral malaria (CM) (n = 86), children with uncomplicated malaria (UM) (n = 81), and community children (CC) (n = 90). Results. Serum VWF, sICAM-1, and sVCAM-1 levels were all elevated in asymptomatic community children with microscopy-confirmed parasitemia when compared with children without parasitemia by microscopy or polymerase chain reaction (all, P .05). Levels of VWF, sICAM-1, and sVCAM-1 were higher in children with UM than in CC (all, P < 0.001), but only VWF levels effectively distinguished CM from UM (P < 0.001), a finding confirmed by receiver operating characteristic analyses (area under the curve = 0.67; 95% confidence interval, .58-.75). Von Willebrand factor levels were lower in children with blood group O versus non-O blood groups across the disease spectrum, but VWF levels remained higher in CM versus UM, even after controlling for blood group. Conclusions. Endothelial activation, as assessed by serum levels of VWF, sICAM-1, and sVCAM-1, occurs even in subclinical P. falciparum parasitemia. Von Willebrand factor levels increase with greater malaria disease severity. Blood group O is associated with lower VWF levels, but presence of blood group O alone does not explain the higher VWF levels seen in children with CM.
Cerebral malaria (CM) is a deadly disease that affects hundreds of thousands of children worldwide [1] . The pathogenesis of CM is not fully defined, but it is thought to involve parasite sequestration in postcapillary venules, leading to tissue hypoxia and ischemic damage, and immune responses to Plasmodium falciparum, notably pro-inflammatory cytokine responses [2] . Parasite sequestration is a hallmark in the brain pathology of children who die of CM (reviewed in [3] ), and activation of endothelial cells by infected erythrocytes and pro-inflammatory cytokines, notably tumor necrosis factor, is thought to contribute to parasite sequestration and attraction of leukocytes and platelets to the areas of microvascular parasite sequestration [4] . However, the process of endothelial activation and the markers that best identify activation are still not clearly understood.
Studies have shown P. falciparum infection and severe malaria correlates with an increase in several markers of endothelial activation, including von Willebrand factor (VWF), soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) [5] [6] [7] [8] [9] [10] [11] . Intercellular adhesion molecule-1 and VCAM-1 bind infected erythrocytes, assist in leukocyte extravasation, and can induce the local release of cytokines as well as the production of tissue factor, which is the principle initiator of coagulation [12, 13] . Von Willebrand factor functions directly in primary hemostasis, mediating platelet binding and aggregation to components of the extracellular matrix, and indirectly in secondary hemostasis as a carrier protein for factor VIII [14] .
In malaria, blood group A has been associated with severe disease and blood group O with protection from severe disease [15, 16] . A number of studies report plasma VWF levels 25%-30% lower in O group individuals than non-O group individuals [17, 18] . We hypothesized that the protection from severe disease afforded by blood group O may be related to decreased endothelial activation in those with this blood group. To test this hypothesis and to assess which marker of endothelial activation best predicts severe disease with malaria, we compared serum levels of VWF, sICAM-1, and sVCAM-1, and O and non-O blood group phenotypes in children with CM, children with uncomplicated malaria (UM), and community children (CC).
METHODS

Study Population and Plasmodium falciparum Detection
The study was conducted at Mulago Hospital, Kampala, Uganda. Children aged 4-12 years with CM (n = 88) or UM (n = 81) or asymptomatic CC (n = 100) were recruited as part of 2 studies assessing the complications of CM. Complete details of the study cohorts and the control samples were previously reported [19] . Written informed consent was obtained from the parents or guardians of study participants. The Institutional review boards for human studies at Makerere University Faculty of Medicine, University Hospitals of Cleveland, Case Western Reserve University, University of Minnesota, and Indiana Wesleyan University granted ethical approval for the study. In addition to microscopy on blood smear, nearly all study participants were screened by polymerase chain reaction (PCR) for P. falciparum according to methods previously published [20] . Asymptomatic parasitemia analyses were performed only on community children in whom both microscopy and PCR testing were done (n = 67).
Immunoassays
Serum samples were available for testing from 86 children with CM, 81 children with UM, and 90 CC, but volume requirements limited the number of samples tested for each assay. Serum samples were kept frozen at −70°C until testing. The relative concentration of VWF (VWF:antigen) is expressed as a percent of normal and was determined using a commercial enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions (Corgenix, Inc). To keep measurements within the range of the standard curve, some samples were additionally diluted either 1:3 or 1:5 from the protocol recommendations in the sample diluent provided in the kit. Serum concentrations of sVCAM-1 and sICAM-1 were measured with commercial ELISAs according to the manufacturer's instructions (R&D Systems) diluted 1:20 in the diluent provided in the kit. At least 10 samples were tested in duplicate in separate assays to assess reliability of sample testing, and the mean differences in replicate values of all assays were <10%.
ABO Blood Group Genotyping
Genomic DNA samples were purified from filter paper blood spots from 77 children with CM, 80 children with UM, and 83 CC using a QIAamp DNA Blood Kit (QIAGEN). Eluted concentrations ranged 1-50 ng/μL. ABO blood group genotyping was performed similar to a method published by Olsson and Chester [21] . Two separate PCR reactions were used to amplify 2 regions of the ABO locus, and enzymatic digestions of the resulting products were used to discriminate between O and non-O blood groups. Although there are limitations in detecting subgroup alleles, hybrid genes, and null genes with this method, the common genotypes with alleles A 
Statistical Analyses
Statistical analyses were performed with STATA SE version 10.1 (StataCorp). Von Willebrand factor, sVCAM-1, and sICAM-1 levels across disease groups and blood type groups were compared with the Wilcoxon rank sum test. ABO blood group frequencies were compared with either Fisher's exact test or Pearson's χ 2 test. Significance was defined at P < .05.
Receiver operating characteristic analyses were performed between groups for each endothelial marker. Multiple comparisons were adjusted for by the Bonferroni correction.
RESULTS
Study Participant Characteristics
Children with CM were more frequently male and younger and had lower hemoglobin levels, lymphocyte counts, and platelet counts than children with UM or CC ( Table 1) . Children with CM also had higher median parasite density than CC but not children with UM (Table 1) . Sixty-seven of the 90 CC were assessed for P. falciparum infection by both microscopy and PCR. Age, sex, weight, hemoglobin level, and lymphocyte count did not differ in children by microscopy or PCR P. falciparum infection status (Table 1) . However, platelet count was lower in children who were microscopy and PCR positive compared with children who were microscopy negative, PCR positive, or microscopy and PCR negative (Table 1) .
Von Willebrand Factor Antigen Levels According to Disease Severity and Parasitemia 
Von Willebrand Factor Antigen Levels According to ABO Blood Group and Disease Severity
There was no significant difference in the frequency of the blood group O phenotype between CC (48%) and children with UM (49% O; P = .94) or CM (44%; P = .61). The percentage with blood group O, A, B, and AB was 44%, 23%, 26%, and 7%, respectively, for children with CM, 49%, 26%, 16%, and 9%, respectively, for children with UM (P = .51 compared with CM), and 48%, 33%, 12%, and 7%, respectively, for CC (P = .14 compared with CM; P = .75 compared with UM). Blood group O was associated with lower VWF levels in all study groups (Figure 2A ). Von Willebrand factor levels were higher in children with CM compared with children with UM whether the children had blood group O (CM vs UM, P = .005) or had a non-O blood group (CM vs UM, P = .009) (Figure 2A ). However, VWF levels between children with CM and blood group O and children with UM and non-O blood groups did not differ significantly (P = .39) (Figure 2A ), highlighting the contribution of blood group O to VWF levels and the importance of assessment of blood group when comparing VWF levels with disease severity.
Von Willebrand factor levels in children with CM with O or non-O blood groups both decreased significantly at a 72-hour time point (P = .02 for O group; P = .03 for non-O groups), but levels in the non-O group remained higher than those in the O group ( Figure 2B) . Von Willebrand factor levels on enrollment correlated strongly with platelet count in children with UM (ρ = −0.50; P < .001) but not in children with CM (ρ = −0.12; P = .32) or asymptomatic CC (ρ = −0.11; P = .59). . sICAM-1 levels do not differ and are not affected by ABO blood group in children with uncomplicated malaria (UM) and cerebral malaria (CM). A, Serum concentrations of sICAM-1 were determined for community children (CC) and children with UM or CM. B, Serum concentrations of sICAM-1 from CC were subgrouped according to the presence or absence of parasites as detected by polymerase chain reaction (PCR) and microscopy (Smear). Only CC with both PCR and microscopy results are shown. C, Serum concentrations of sICAM-1 were subgrouped by O and non-O blood group. Dot plots show the resulting distribution of values (ng/mL), with medians indicated on the plot with vertical gray bars, and the bracketed numbers indicate number of samples tested. Group levels were compared with Wilcoxon rank sum tests and P values are reported for the indicated group comparisons.
Levels of sICAM-1 did not differ between children with O versus non-O blood group regardless of whether the children had CM or UM or were CC (all, P > .05) ( Figure 3C ). No significant differences of sICAM-1 levels were seen between children with any individual blood group (data not shown).
Levels Figure 4B ). However, the sVCAM-1 levels of the microscopy-positive CC were significantly lower than those in children with UM (P < .001) (data not shown). Levels of sVCAM-1 correlated to parasite density in children with CM (ρ = 0.30; P = .007) or UM (ρ = 0.43; P < .001) and in microscopypositive CC (ρ = 0.53; P = .001).
Soluble vascular cell adhesion molecule-1 levels did not differ by O versus non-O blood group in children with CM or UM but were higher in non-O compared with O blood group CC (P = .02) ( Figure 4C ). As with sICAM-1, levels of sVCAM-1 in children with UM and CM did not differ significantly according to specific blood group (data not shown). There were no correlations of sICAM-1 levels with platelet counts in any group, but sVCAM-1 levels were correlated with platelet counts in children with CM (ρ = −0.37; P = .001) or UM (ρ = −0.44; P < .001).
Prediction of Disease Severity and Mortality by Von Willebrand Factor, sICAM-1, and sVCAM-1
Receiver operating characteristic analysis was performed for VWF, sICAM-1, and sVCAM-1. The area under the curve (AUC) for a marker that perfectly differentiates CM from UM is 1.0, whereas an AUC value of 0.5 reflects a lack of discrimination between CM and UM. Von Willebrand factor predicted disease severity better than sICAM-1 or sVCAM- 
DISCUSSION
In this study, we document that serum levels of VWF distinguish between asymptomatic children with peripheral blood parasitemia by microscopy compared with asymptomatic children without peripheral blood parasitemia by microscopy, and serum levels of VWF also distinguish UM from CM. Although levels of VWF were lower in children with blood group O, blood group alone did not account for the differences seen in VWF levels between children with UM versus CM. Serum levels of 2 other markers of endothelial activation, sICAM-1 and sVCAM-1, were also higher in asymptomatic children with peripheral blood parasitemia compared with asymptomatic children without parasitemia but did not distinguish UM from CM. Our findings provide evidence that endothelial activation occurs in asymptomatic children with peripheral P. falciparum parasitemia, at least at the level required for detection by microscopy, and suggest that VWF may be a particularly useful marker of endothelial activation in malaria. Our findings also provide impetus for further assessment of the role of VWF in the pathogenesis of severe malaria and UM.
Among the most interesting study findings was that endothelial activation as measured by all 3 markers was seen even in children with asymptomatic parasitemia, if parasitemia reached the level detectable by microscopy. In a prior study in which malaria-naive humans were infected with P. falciparum, endothelial activation as assessed by elevated VWF levels occurred when parasitemia was detected by PCR, prior to detection by microscopy. In the present study, children in a malaria-endemic area demonstrated elevation of VWF levels only when parasitemia reached levels detected by microscopy. The differences may relate to a difference in endothelial responses to P. falciparuminfected erythrocytes in a malaria-naive host versus a previously malaria-exposed host [6] . Chronic endothelial activation in other diseases (eg, sickle cell anemia [24] , systemic lupus erythematosus [25] ) appears to lead to adverse outcomes, including endothelial dysfunction, atherosclerosis, vasoocclusion, and multiple organ damage. Our study findings have shown cognitive impairment in children with CM [26] , but other studies have shown developmental consequences even in children with repeated episodes of UM [27] . Children in highly malaria-endemic areas frequently have chronic asymptomatic parasitemia by microscopy [28, 29] . If endothelial activation affects brain vascular tone or causes other pathophysiology that leads to neuronal activation or damage, then the chronic endothelial activation in children with chronic subpatent parasitemia could adversely affect neurodevelopment. Chronic endothelial activation could also lead to other complications such as ischemia and reperfusion injuries or apoptosis of endothelial cells leading to a breakdown of the microvascular barrier [30] . The finding of endothelial activation in asymptomatic parasitemia suggests that chronic subclinical parasitemia could have adverse long-term clinical consequences [31] . In addition, the finding of a lower platelet count in children with asymptomatic parasitemia at the level detectable by microscopy further supports the presence of a subclinical hematological response to P. falciparum in these children. Future studies should assess endothelial activation in children with repeated asymptomatic parasitemia and whether chronic neurodevelopmental or cardiac disease is more frequent in these children on long-term follow-up. Any association of chronic endothelial activation with chronic disease would provide a further argument for malaria elimination as opposed to control.
Von Willebrand factor, but not ICAM-1 or VCAM-1, discriminated between those with severe versus mild disease, suggesting that VWF not only reflects endothelial activation but may be involved in disease pathogenesis. Our study findings confirm those of recently published studies in which VWF and VWF propeptide levels were higher in children with CM than in children with mild malaria [8, 9] . The present study adds to these studies by assessing levels of additional markers of endothelial activation (ICAM-1, VCAM-1), investigating levels in asymptomatic parasitemia, and assessing the contribution of blood group to VWF levels across the disease spectrum. Whereas ICAM-1 and VCAM-1 can bind infected erythrocytes (IEs) to endothelial cells, providing a mechanism for the sequestration of IEs, VWF is thought to mediate IE adhesion to endothelial cells via platelets and CD36 [32, 33] . Platelets may play a role in killing asexual blood stages of P. falciparum [34] , so increases in VWF might lead to an increase in disease severity because of the role of VWF in binding platelets and inhibiting their protective effect, in addition to providing another mechanism for the sequestration of IEs [34] . In support of this, we found that levels of VWF were negatively correlated with platelet counts (ρ = −0.50; P < .001) and parasitemia in children with UM. Von Willebrand factor activity might also contribute to the thrombocytopenia seen in severe malaria, though recent studies have suggested that thrombocytopenia is not a result of consumptive coagulopathy [35] .
Other studies have shown decreased plasma concentrations and activity of the VWF processing enzyme ADAMTS13 in severe P. falciparum malaria [36] [37] [38] . ADAMTS13 specifically cleaves ultralarge (UL)-VWF in conditions of fluid stress into less active/prothrombotic, lower molecular weight multimers [39] . It would be of interest to determine if the children with asymptomatic parasitemia had a decrease in ADAMTS13 activity and/or an increase in UL-VWF multimers. Such investigations would help to elucidate the effect of a low-level parasitemia on a chronic activation of the endothelium.
Blood group differences explained some, but not all, of the differences in VWF levels between children with UM and severe malaria. Von Willebrand factor contains ABO N-linked and O-linked glycosylation sites, and VWF proteolysis by ADAMTS13 differs between blood groups in the processing of UL-VWF into dimeric proteolytic fragments [40] [41] [42] . Because O group individuals have no A or B carbohydrates, VWF is processed more readily, leading to lower levels of UL-VWF. It has also been shown that ADAMTS13 functional activity on VWF can be influenced by ABO blood group via sialylation [41, 43] . These findings suggest mechanisms by which the previously documented association of blood group O with protection from severe malaria [15, 44] may be mediated in part by alterations in VWF processing and level. Our study demonstrates that assessment of ABO blood group is critical when analyzing VWF levels in populations with severe malaria. Future studies should further assess the mechanisms by which ABO group may alter VWF level and function in severe malaria.
In summary, this study provides strong evidence that endothelial activation occurs even in children with asymptomatic P. falciparum parasitemia and that VWF levels distinguish CM from UM. Although VWF levels were lower in children with blood group O compared with children with non-O blood groups, blood group alone did not account for the differences seen in VWF levels between children with UM versus CM. Future studies should assess whether VWF interactions with blood group and platelets play a role in malaria pathogenesis and whether chronic endothelial activation in children with asymptomatic parasitemia is associated with long-term developmental or other consequences.
